Humanitarian Impact & Innovation: How the ICRC and Novartis are Tackling Noncommunicable Diseases

Humanitarian Impact & Innovation: How the ICRC and Novartis are Tackling Noncommunicable Diseases

With a migrant population of more than one million people who have fled the fighting in Syria, refugees now account for about one-third of Lebanon’s population. Those suffering from chronic diseases face difficulties accessing diagnosis, medicines and ongoing care. The ICRC and Novartis are partnering to improve care and treatment for the most vulnerable population in Lebanon.

Read More